News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Lonza Group Ltd. to Invest $150 Million in Genome Valley
May 22, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PharmaBiz -- Switzerland-based Lonza, one of the global biopharmaceutical giants, would make an investment of US $150 million (around Rs 750 crore) for two major projects in Genome Valley, which is located at the outskirts of Hyderabad.
Twitter
LinkedIn
Facebook
Email
Print
Asia
Lonza
MORE ON THIS TOPIC
Obesity
AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront
January 30, 2026
·
2 min read
·
Tristan Manalac
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
January 29, 2026
·
1 min read
·
Tristan Manalac
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
January 28, 2026
·
4 min read
·
Heather McKenzie
JPM
JPM26: Biopharma Projected Positivity in San Francisco. Now It’s Time To Execute
January 27, 2026
·
6 min read
·
Annalee Armstrong
